Is lorcaserin really associated with increased risk of cancer? A systematic review and meta-analysis
{{output}}
The US Food and Drug Administration (FDA) reported in February 2020 an increased risk of cancer with lorcaserin in the follow-up of the CAMELLIA-TIMI 61 trial. This systematic review and meta-analysis addresses whether lorcaserin is associated with higher inci... ...
